Entera Bio (ENTX) Prepaid Assets (2017 - 2026)
Entera Bio's (ENTX) quarterly Prepaid Assets came in at $566000.0 in Q1 2026, up 9.06% YoY from $519000.0 in Q1 2025, and up 36.39% on a QoQ basis from $415000.0 in Q4 2025.
Entera Bio (ENTX) Prepaid Assets (2017 - 2026) Analysis & Trends
Entera Bio (ENTX) has 10 years of Prepaid Assets data on file, last reported at $566000.0 in Q1 2026.
- Quarterly Prepaid Assets rose 9.06% year-over-year to $566000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $566000.0 (up 9.06% YoY) and the FY2025 annual result came in at $415000.0, up 123.12% from the prior year.
- Prepaid Assets improved to $566000.0 in Q1 2026, from $415000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.3 million in Q1 2022 to a low of $186000.0 in Q4 2024.
- A 5-year average of $535294.1 and a median of $482000.0 in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets plunged 50.61% — and 2025, when it jumped 123.12%.
- Tracing ENTX's Prepaid Assets over 5 years: stood at $294000.0 in 2022, then slipped by 19.05% to $238000.0 in 2023, then decreased by 21.85% to $186000.0 in 2024, then surged by 123.12% to $415000.0 in 2025, then surged by 36.39% to $566000.0 in 2026.
- The last three Prepaid Assets figures came in at $566000.0 (Q1 2026), $415000.0 (Q4 2025), and $405000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Entera Bio | 161.44 Mn | 150.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 465,000.00 |
| Mar 31, 2026 | 566,000.00 |
| Dec 31, 2025 | 415,000.00 |
| Sep 30, 2025 | 405,000.00 |
| Jun 30, 2025 | 438,000.00 |
| Mar 31, 2025 | 519,000.00 |
| Dec 31, 2024 | 186,000.00 |
| Sep 30, 2024 | 383,000.00 |
| Jun 30, 2024 | 482,000.00 |
| Mar 31, 2024 | 562,000.00 |
| Dec 31, 2023 | 238,000.00 |
| Sep 30, 2023 | 431,000.00 |
| Jun 30, 2023 | 650,000.00 |
| Mar 31, 2023 | 653,000.00 |
| Dec 31, 2022 | 294,000.00 |
| Sep 30, 2022 | 634,000.00 |
| Jun 30, 2022 | 922,000.00 |
| Mar 31, 2022 | 1.32 Mn |
| Dec 31, 2021 | 254,000.00 |
| Dec 31, 2020 | 261,000.00 |